Functional study on new FOXL2 mutations found in Chinese patients with blepharophimosis, ptosis, epicanthus inversus syndrome

Abstract Background Blepharophimosis, ptosis, epicanthus inversus syndrome (BPES) is a rare inheritable disease that mainly affects eyelid development associated with (type I) or without (type II) ovarian dysfunction, resulting in premature ovarian failure (POF). Mutations in the gene forkhead box L...

Full description

Bibliographic Details
Main Authors: Lu Zhou, Jiaqi Wang, Tailing Wang
Format: Article
Language:English
Published: BMC 2018-07-01
Series:BMC Medical Genetics
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12881-018-0631-8
_version_ 1831685243215544320
author Lu Zhou
Jiaqi Wang
Tailing Wang
author_facet Lu Zhou
Jiaqi Wang
Tailing Wang
author_sort Lu Zhou
collection DOAJ
description Abstract Background Blepharophimosis, ptosis, epicanthus inversus syndrome (BPES) is a rare inheritable disease that mainly affects eyelid development associated with (type I) or without (type II) ovarian dysfunction, resulting in premature ovarian failure (POF). Mutations in the gene forkhead box L2 (FOXL2) have been shown to be responsible for BPES. The aim of this study was to determine and functionally validate the FOXL2 mutation in a Chinese BPES family. Methods Twelve individuals including five BPES patients from a Chinese family were enrolled. Genomic DNA was extracted from peripheral blood of enrolled subjects. The coding region of the FOXL2 gene was amplified and mutations were determined by sequencing analyses. Functional analysis was carried out to study changes in expression and transcriptional activity of the mutant FOXL2 protein. Results A novel mutation in the FOXL2 gene (c.931C > T) was detected in all five BPES patients, which converts a histidine residue into a tyrosine (p.H311Y) in the FOXL2 protein. Functional analysis revealed that this point mutation reduces FOXL2 protein expression, concomitant with decreased transcriptional activity on the steroidogenic acute regulatory (StAR) gene promotor. Conclusions Our results expand the mutational spectrum of the FOXL2 gene and provide additional insights to the research on the molecular pathogenesis of FOXL2 in BPES.
first_indexed 2024-12-20T08:17:06Z
format Article
id doaj.art-a5fa673115674e6c96d74f249faa4e59
institution Directory Open Access Journal
issn 1471-2350
language English
last_indexed 2024-12-20T08:17:06Z
publishDate 2018-07-01
publisher BMC
record_format Article
series BMC Medical Genetics
spelling doaj.art-a5fa673115674e6c96d74f249faa4e592022-12-21T19:47:06ZengBMCBMC Medical Genetics1471-23502018-07-011911710.1186/s12881-018-0631-8Functional study on new FOXL2 mutations found in Chinese patients with blepharophimosis, ptosis, epicanthus inversus syndromeLu Zhou0Jiaqi Wang1Tailing Wang2The 3rd Department, Plastic Surgery Hospital of the Chinese Academy of Medical Sciences, Peking Union Medical CollegeThe 3rd Department, Plastic Surgery Hospital of the Chinese Academy of Medical Sciences, Peking Union Medical CollegeThe 3rd Department, Plastic Surgery Hospital of the Chinese Academy of Medical Sciences, Peking Union Medical CollegeAbstract Background Blepharophimosis, ptosis, epicanthus inversus syndrome (BPES) is a rare inheritable disease that mainly affects eyelid development associated with (type I) or without (type II) ovarian dysfunction, resulting in premature ovarian failure (POF). Mutations in the gene forkhead box L2 (FOXL2) have been shown to be responsible for BPES. The aim of this study was to determine and functionally validate the FOXL2 mutation in a Chinese BPES family. Methods Twelve individuals including five BPES patients from a Chinese family were enrolled. Genomic DNA was extracted from peripheral blood of enrolled subjects. The coding region of the FOXL2 gene was amplified and mutations were determined by sequencing analyses. Functional analysis was carried out to study changes in expression and transcriptional activity of the mutant FOXL2 protein. Results A novel mutation in the FOXL2 gene (c.931C > T) was detected in all five BPES patients, which converts a histidine residue into a tyrosine (p.H311Y) in the FOXL2 protein. Functional analysis revealed that this point mutation reduces FOXL2 protein expression, concomitant with decreased transcriptional activity on the steroidogenic acute regulatory (StAR) gene promotor. Conclusions Our results expand the mutational spectrum of the FOXL2 gene and provide additional insights to the research on the molecular pathogenesis of FOXL2 in BPES.http://link.springer.com/article/10.1186/s12881-018-0631-8BPESFOXL2Gene mutation
spellingShingle Lu Zhou
Jiaqi Wang
Tailing Wang
Functional study on new FOXL2 mutations found in Chinese patients with blepharophimosis, ptosis, epicanthus inversus syndrome
BMC Medical Genetics
BPES
FOXL2
Gene mutation
title Functional study on new FOXL2 mutations found in Chinese patients with blepharophimosis, ptosis, epicanthus inversus syndrome
title_full Functional study on new FOXL2 mutations found in Chinese patients with blepharophimosis, ptosis, epicanthus inversus syndrome
title_fullStr Functional study on new FOXL2 mutations found in Chinese patients with blepharophimosis, ptosis, epicanthus inversus syndrome
title_full_unstemmed Functional study on new FOXL2 mutations found in Chinese patients with blepharophimosis, ptosis, epicanthus inversus syndrome
title_short Functional study on new FOXL2 mutations found in Chinese patients with blepharophimosis, ptosis, epicanthus inversus syndrome
title_sort functional study on new foxl2 mutations found in chinese patients with blepharophimosis ptosis epicanthus inversus syndrome
topic BPES
FOXL2
Gene mutation
url http://link.springer.com/article/10.1186/s12881-018-0631-8
work_keys_str_mv AT luzhou functionalstudyonnewfoxl2mutationsfoundinchinesepatientswithblepharophimosisptosisepicanthusinversussyndrome
AT jiaqiwang functionalstudyonnewfoxl2mutationsfoundinchinesepatientswithblepharophimosisptosisepicanthusinversussyndrome
AT tailingwang functionalstudyonnewfoxl2mutationsfoundinchinesepatientswithblepharophimosisptosisepicanthusinversussyndrome